UniPharma Co., Ltd. (TPEX:6621)
Taiwan · Delayed Price · Currency is TWD 11.45
0.00 (0.00%)
Sep 8, 2026, 12:51 PM CST
UniPharma Market Cap
UniPharma has a market cap or net worth of 406.49 million as of September 4, 2026. Its market cap has decreased by -9.84% in one year.
Market Cap
406.49M
Enterprise Value
311.22M
Revenue
83.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.45
ChartMarket Cap Chart
Since August 18, 2017, UniPharma's market cap has decreased from 679.51M to 406.49M, a decrease of -40.18%. That is a compound annual growth rate of -5.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 406.49M | -5.76% |
| Dec 31, 2025 | 431.34M | -12.27% |
| Dec 31, 2024 | 491.69M | -6.42% |
| Dec 29, 2023 | 525.41M | -4.52% |
| Dec 30, 2022 | 550.27M | 37.73% |
| Dec 30, 2021 | 399.53M | -25.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.33B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.15B |
| Prince Pharmaceutical | 1.06B |
| DV Biomed | 999.53M |
| Anxo Pharmaceutical | 969.47M |
| Original BioMedicals | 881.87M |
| Winston Medical Supply | 812.19M |